In High-Stakes Meetings, 340B Stakeholders Push to Sway HHS’ Rebate Guidance Ahead of Release

More than a dozen stakeholder groups haver recently met with federal officials about HHS' highly-anticipated 340B rebate guidance.
In a flurry of meetings with federal officials, drug industry and provider groups are making a final push to influence [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

New Oregon Law Lets Health Centers Report 340B Claims Through Clearinghouse Instead of PBMs

A new Oregon law grants certain covered entities new flexibility in how they report 340B claims involving PBMs.
Oregon has enacted a new law granting health centers and certain grantees more flexibility in how they report 340B claims [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Roundup: Updates in Tennessee and Utah

Key briefs were filed in litigation on contract pharmacy access laws in Tennessee and Utah.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Providers Slam Newly Enacted GOP Budget Law Over Deep Medicaid Cuts

President Donald Trump on July 4 signed a reconciliation bill with controversial Medicaid cuts that providers strongly criticized.
Provider groups are sharply criticizing the newly enacted, GOP-backed budget reconciliation bill, warning that its more than $1 trillion in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

California Senate Amends 340B Contract Pharmacy Access Bill to Add Provider Reporting, Audit Requirements

The California Senate Health Committee recently amended a 340B contract pharmacy access bill to add new audit and reporting requirements.
California state senators have amended new provider reporting and auditing requirements onto a bill barring drugmakers from placing 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

New York Assembly Honors Longtime 340B Advocate Mark Malahosky on Retirement

New York Assemblymember Harry Bronson (D) honored longtime 340B advcoate Mark Malahosky with a resolution commemorating his retirement. (Credit:Trillium Health/Facebook)
The New York State Assembly recently honored longtime pharmacy leader and 340B advocate Mark Malahosky with a resolution commemorating his [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Two Drugmakers Sue Oklahoma Over New 340B Contract Pharmacy Access Law

Drugmakers AbbVie and Novartis each filed federal lawsuits challenging Oklahoma's 340B contract pharamcy access law.
Two large drug companies this week filed federal lawsuits seeking to strike down Oklahoma’s new law prohibiting drugmaker 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

PhRMA Sues Vermont Over New 340B Contract Pharmacy Access Law

PhRMA recently filed a federal lawsuit challenging the 340B contract pharmacy protections included in a new Vermont law.
A major brand-name drug industry trade group recently filed the first federal lawsuit challenging Vermont’s newly enacted 340B contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Kentucky Launches Voluntary 340B Claims Program Enabling Providers to Carve in Medicaid MCO

Kentucky's state Medicaid program launched a new 340B claims process for Medicaid MCO claims.
Kentucky’s Medicaid program this week launched a new 340B claims submission process that enables covered entities to carve in Medicaid [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

J&J Appeals 340B Rebate Ruling, Hospitals Laud Federal Judge’s Rejection of Drugmaker Lawsuit

Johnson & Johnson is appealing a Washington, D.C. federal district judge's ruling on the drugmaker's 340B rebate proposal.
Johnson & Johnson (J&J) has formally appealed a federal judge’s ruling that drugmakers cannot unilaterally implement a 340B rebate model—a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live